Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S24 is a component of the small (40S) ribosomal subunit, crucial for cellular protein synthesis. It is encoded by the RPS24 gene located on chromosome 10. RPS24 takes part in the maturation and processing of pre-rRNA and assembly of the small ribosomal subunit[1][2][3][6]. Besides its primary structural and translational role, ribosomal protein S24 has been implicated in the regulation of cell division and apoptosis. Mutations in RPS24 are associated with Diamond-Blackfan anemia, a rare congenital bone marrow failure characterized by anemia and physical anomalies. Recent research suggests alternative splicing of RPS24 may be linked to cancer biology, but it is not currently recognized as a direct therapeutic target for drug development[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S24 (RPS24).